A recently discovered inhibitor shows new ways for the development of mRNA-based drugs.mRNA-based therapeutics and vaccines ...

RNA-based therapeutics and vaccines are the new hope in the fight against incurable diseases. A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction ...

A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing mRNA. Achieving the opposite and stabilizing health-promoting mRNA is still ...

The work presented will be of interest to cancer biologists and more broadly to those interested in NSCLC translational studies. Non-small cell lung cancer (NSCLC) is the most common subtype of lung ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

Moderna (MRNA) closed at $58.39 in the latest trading ... Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Ensure to harness Zacks.com to ...

About half a million people in the U.S. contract C ... Now, researchers have developed an mRNA vaccine that protected mice from succumbing to C. diff infections and prevented recurring cases.

Moderna (MRNA) closed at $63.94 in the latest trading ... Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Keep in mind to rely on Zacks.com ...

A team of researchers at the University of Pennsylvania took a new approach, using mRNA technology to design a multipronged vaccine that targets several proteins that underlie C. difficile’s ...

with contributions expected to materialize in the second half of 2024. Maravai continues to make progress in addressing the complete mRNA workflow through new product introductions. A notable ...